Publication | Closed Access

Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing–remitting multiple sclerosis treated with interferon beta

CytokineAutoimmune DiseaseImmune RegulationImmunologyPathologyTissue InhibitorAutoimmunityImmunologic DiseaseMultiple SclerosisMedicineCell TransplantationNeuroimmunologyMatrix Metalloproteinase